United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
499.73
-1.54 (-0.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed
United Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, United Therapeutics stock has a consensus rating of "Buy" and an average price target of $653.23. The average 1-year stock price forecast is 30.72% higher than the current stock price, while the lowest is $515 (+3.06%) and the highest is $725 (+45.08%).
Price Target: $653.23 (+30.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $660 | Buy | Maintains | $660 | +32.07% | Aug 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $738 → $700 | Buy | Reiterates | $738 → $700 | +40.08% | Aug 6, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $516 → $515 | Hold | Reiterates | $516 → $515 | +3.06% | Aug 6, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $704 → $677 | Buy | Reiterates | $704 → $677 | +35.47% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $675 | Buy | Maintains | $675 | +35.07% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
3.15B
from 3.18B
Decreased by -1.17%
Revenue Next Year
3.48B
from 3.15B
Increased by 10.77%
EPS This Year
28.05
from 27.86
Increased by 0.69%
EPS Next Year
30.15
from 28.05
Increased by 7.48%
EPS and Forward PE are based on non-GAAP adjusted numbers.